Shan Jiang, received her Ph.D. degree in Industrial and Physical Pharmacy from Purdue University. She has over 15 years industry experience in protein formulation development, clinical and commercial manufacturing of biological drug products. She has worked in several pharmaceutical and biotechnology companies. Her current position is Director of Formulation and Fill/Finish Department in Seattle Genetics Inc, focusing on antibody-drug conjugates (ADC) development and manufacturing.
She is an active member in various scientific/technology communities, and has been invited to speak at Lyophilization Conferences, Formulation Strategy Conferences, and IBC Conferences in US, Europe, and Asia.